Newsletter 5/2023
Delve deeper into the insights provided by the recent PREEMPT-HF trial and the posters featuring findings from two HeartLogic studies presented at the HFSA 2023 Congress.
Newsletter 4/2023
Delve into the main takeaways from the recent HeartLogicTM and Remote Monitoring publications, and explore three abstracts related to HeartLogic that were showcased at the ESC Congress 2023.
Newsletter 3/2023
Go through some key messages from the latest publications on HeartLogicTM algorithm as we provide insights into its clinical benefits and performance.
Newsletter 2/2023
Explore the latest research on HeartLogicTM, a cutting-edge algorithm that effectively predicts all-cause mortality, ventricular arrhythmias, and atrial fibrillation events in heart failure patients.
Newsletter 1/2023
Discover the latest advancements in remote monitoring of cardiac devices and its impact on long-term mortality.
HEARTLOGIC™ Newsletter 2020-2022
Have a look at our previous newsletters about HeartLogic from Boston Scientific
CAUTION:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries.
This material not intended for use in France.